(-)-epigallocatechin 3-gallate decreases expression ISO XRCC5 (Homo sapiens) 6480464 epigallocatechin gallate results in decreased expression of XRCC5 protein CTD PMID:31195006 (-)-quinic acid multiple interactions ISO XRCC5 (Homo sapiens) 6480464 [Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of XRCC5 mRNA CTD PMID:21751221 (1->4)-beta-D-glucan multiple interactions ISO Xrcc5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of XRCC5 mRNA CTD PMID:36331819 (S)-naringenin multiple interactions ISO XRCC5 (Homo sapiens) 6480464 [naringenin metabolite co-treated with bisphenol A] results in decreased expression of XRCC5 mRNA CTD PMID:36235125 1,2-dimethylhydrazine multiple interactions ISO Xrcc5 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of XRCC5 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO Xrcc5 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of XRCC5 mRNA CTD PMID:17555576 17beta-estradiol increases expression ISO XRCC5 (Homo sapiens) 6480464 Estradiol results in increased expression of XRCC5 mRNA CTD PMID:16514628 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one decreases expression ISO XRCC5 (Homo sapiens) 6480464 Metribolone results in decreased expression of XRCC5 protein CTD PMID:17152098 2,2'-dithiodiethanol multiple interactions ISO XRCC5 (Homo sapiens) 6480464 [2-hydroxyethyl disulfide co-treated with Glucose deficiency] results in decreased activity of [XRCC5 protein binds to XRCC6 protein] CTD PMID:22926048 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Xrcc5 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin affects the methylation of XRCC5 intron] which results in decreased expression of XRCC5 mRNA CTD PMID:33017471 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of XRCC5 mRNA CTD PMID:21346803 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of XRCC5 protein CTD PMID:34915118 4,4'-diaminodiphenylmethane increases expression ISO Xrcc5 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of XRCC5 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO XRCC5 (Homo sapiens) 6480464 bisphenol S results in increased expression of XRCC5 protein CTD PMID:34186270 4-amino-1,8-naphthalimide affects response to substance ISO Xrcc5 (Mus musculus) 6480464 XRCC5 protein affects the susceptibility to 4-amino-1 and 8-naphthalimide CTD PMID:16556909 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2 and 6-dinitrotoluene affects the expression of XRCC5 mRNA CTD PMID:21346803 4-hydroperoxycyclophosphamide decreases expression EXP 6480464 perfosfamide results in decreased expression of XRCC5 mRNA CTD PMID:11754170 4-hydroxyphenyl retinamide increases expression ISO Xrcc5 (Mus musculus) 6480464 Fenretinide results in increased expression of XRCC5 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO XRCC5 (Homo sapiens) 6480464 Decitabine affects the expression of XRCC5 mRNA CTD PMID:23300844 5-fluorouracil multiple interactions ISO XRCC5 (Homo sapiens) 6480464 XRCC5 mRNA results in increased susceptibility to [Fluorouracil co-treated with Cisplatin] CTD PMID:18546291 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of XRCC5 mRNA CTD PMID:30047161 afimoxifene decreases expression ISO XRCC5 (Homo sapiens) 6480464 afimoxifene results in decreased expression of XRCC5 mRNA CTD PMID:16514628 aflatoxin B1 decreases methylation ISO XRCC5 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of XRCC5 gene CTD PMID:27153756 Aflatoxin B2 alpha increases methylation ISO XRCC5 (Homo sapiens) 6480464 aflatoxin B2 results in increased methylation of XRCC5 intron CTD PMID:30157460 aldehydo-D-glucose multiple interactions ISO XRCC5 (Homo sapiens) 6480464 [2-hydroxyethyl disulfide co-treated with Glucose deficiency] results in decreased activity of [XRCC5 protein binds to XRCC6 protein] CTD PMID:22926048 all-trans-retinoic acid increases expression ISO XRCC5 (Homo sapiens) 6480464 Tretinoin results in increased expression of XRCC5 protein CTD PMID:20888851 amiodarone increases expression ISO Xrcc5 (Mus musculus) 6480464 Amiodarone results in increased expression of XRCC5 mRNA CTD PMID:24489787 amitrole increases expression EXP 6480464 Amitrole results in increased expression of XRCC5 mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of XRCC5 mRNA CTD PMID:16483693 aristolochic acid A decreases expression ISO XRCC5 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of XRCC5 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO Xrcc5 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of XRCC5 mRNA CTD PMID:23650126 arsane increases expression ISO XRCC5 (Homo sapiens) 6480464 Arsenic results in increased expression of XRCC5 protein CTD PMID:19818359 arsenic atom increases expression ISO XRCC5 (Homo sapiens) 6480464 Arsenic results in increased expression of XRCC5 protein CTD PMID:19818359 arsenous acid increases expression ISO XRCC5 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of XRCC5 mRNA CTD PMID:22521957 atrazine decreases expression ISO XRCC5 (Homo sapiens) 6480464 Atrazine results in decreased expression of XRCC5 mRNA CTD PMID:22378314 benzene increases expression ISO Xrcc5 (Mus musculus) 6480464 Benzene results in increased expression of XRCC5 mRNA CTD PMID:15342939 benzene decreases expression ISO Xrcc5 (Mus musculus) 6480464 Benzene results in decreased expression of XRCC5 mRNA CTD PMID:35963423 benzo[a]pyrene increases expression ISO Xrcc5 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of XRCC5 mRNA CTD PMID:20504355 benzo[a]pyrene increases methylation ISO XRCC5 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of XRCC5 3' UTR CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO XRCC5 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of XRCC5 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO XRCC5 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of XRCC5 mRNA CTD PMID:28461126 biphenyl-4-amine multiple interactions ISO XRCC5 (Homo sapiens) 6480464 Propolis inhibits the reaction [4-biphenylamine results in decreased expression of XRCC5 protein] and TP53 protein inhibits the reaction [4-biphenylamine results in decreased expression of XRCC5 mRNA] CTD PMID:32905825 and PMID:33847444 biphenyl-4-amine decreases expression ISO XRCC5 (Homo sapiens) 6480464 4-biphenylamine results in decreased expression of XRCC5 mRNA and 4-biphenylamine results in decreased expression of XRCC5 protein CTD PMID:32905825 and PMID:33847444 bis(2-ethylhexyl) phthalate multiple interactions ISO Xrcc5 (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of and results in increased stability of and results in increased methylation of XRCC5 mRNA and METTL3 promotes the reaction [Diethylhexyl Phthalate results in increased expression of and results in increased stability of and results in increased methylation of XRCC5 mRNA] CTD PMID:36423848 bis(2-ethylhexyl) phthalate affects expression ISO Xrcc5 (Mus musculus) 6480464 Diethylhexyl Phthalate affects the expression of XRCC5 protein CTD PMID:36423848 bisphenol A multiple interactions ISO XRCC5 (Homo sapiens) 6480464 [naringenin metabolite co-treated with bisphenol A] results in decreased expression of XRCC5 mRNA and bisphenol A inhibits the reaction [PRKDC protein binds to XRCC5 protein] CTD PMID:23227178 and PMID:36235125 bisphenol A decreases methylation ISO XRCC5 (Homo sapiens) 6480464 bisphenol A results in decreased methylation of XRCC5 promoter CTD PMID:36572933 bisphenol A decreases expression ISO XRCC5 (Homo sapiens) 6480464 bisphenol A results in decreased expression of XRCC5 protein CTD PMID:34186270 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of XRCC5 mRNA CTD PMID:30816183 bisphenol A affects methylation ISO Xrcc5 (Mus musculus) 6480464 bisphenol A affects the methylation of XRCC5 promoter CTD PMID:27334623 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of XRCC5 gene CTD PMID:28505145 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of XRCC5 mRNA CTD PMID:25181051 Bisphenol B increases expression ISO XRCC5 (Homo sapiens) 6480464 bisphenol B results in increased expression of XRCC5 protein CTD PMID:34186270 bisphenol F increases expression ISO XRCC5 (Homo sapiens) 6480464 bisphenol F results in increased expression of XRCC5 protein CTD PMID:34186270 bleomycin A2 affects response to substance ISO XRCC5 (Homo sapiens) 6480464 XRCC5 protein affects the susceptibility to Bleomycin CTD PMID:12384553 cadmium atom multiple interactions ISO XRCC5 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XRCC5 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO XRCC5 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of XRCC5 mRNA CTD PMID:35301059 caffeine decreases expression ISO XRCC5 (Homo sapiens) 6480464 Caffeine results in decreased expression of XRCC5 protein CTD PMID:31195006 caffeine decreases phosphorylation ISO XRCC5 (Homo sapiens) 6480464 Caffeine results in decreased phosphorylation of XRCC5 protein CTD PMID:35688186 calcitriol decreases expression ISO XRCC5 (Homo sapiens) 6480464 Calcitriol results in decreased expression of XRCC5 mRNA CTD PMID:15951637 carbonyl cyanide p-trifluoromethoxyphenylhydrazone decreases expression ISO XRCC5 (Homo sapiens) 6480464 Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone results in decreased expression of XRCC5 mRNA CTD PMID:16039398 chlorpyrifos decreases expression ISO Xrcc5 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of XRCC5 mRNA CTD PMID:37019170 cisplatin multiple interactions ISO XRCC5 (Homo sapiens) 6480464 XRCC5 mRNA results in increased susceptibility to [Fluorouracil co-treated with Cisplatin] CTD PMID:18546291 cisplatin affects expression ISO XRCC5 (Homo sapiens) 6480464 Cisplatin affects the expression of XRCC5 mRNA CTD PMID:23300844 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of XRCC5 mRNA CTD PMID:17602206 cobalt dichloride decreases expression ISO XRCC5 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of XRCC5 mRNA CTD PMID:19320972 and PMID:19376846 curcumin decreases expression ISO XRCC5 (Homo sapiens) 6480464 Curcumin results in decreased expression of XRCC5 mRNA CTD PMID:17596214 cyproconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of XRCC5 mRNA CTD PMID:29038839 D-glucose multiple interactions ISO XRCC5 (Homo sapiens) 6480464 [2-hydroxyethyl disulfide co-treated with Glucose deficiency] results in decreased activity of [XRCC5 protein binds to XRCC6 protein] CTD PMID:22926048 diarsenic trioxide increases expression ISO XRCC5 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of XRCC5 mRNA CTD PMID:22521957 dibutyl phthalate decreases expression ISO Xrcc5 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of XRCC5 mRNA CTD PMID:17361019 dicrotophos decreases expression ISO XRCC5 (Homo sapiens) 6480464 dicrotophos results in decreased expression of XRCC5 mRNA CTD PMID:28302478 diethylstilbestrol increases expression ISO Xrcc5 (Mus musculus) 6480464 Diethylstilbestrol results in increased expression of XRCC5 mRNA CTD PMID:22467019 disodium selenite increases expression ISO XRCC5 (Homo sapiens) 6480464 Sodium Selenite results in increased expression of XRCC5 mRNA CTD PMID:18175754 doxorubicin increases expression ISO Xrcc5 (Mus musculus) 6480464 Doxorubicin results in increased expression of XRCC5 protein CTD PMID:24812279 doxorubicin decreases expression ISO XRCC5 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of XRCC5 mRNA CTD PMID:29803840 doxorubicin multiple interactions ISO Xrcc5 (Mus musculus) 6480464 [STAT3 gene mutant form results in increased susceptibility to Doxorubicin] which results in increased expression of XRCC5 protein more ... CTD PMID:24812279 endosulfan decreases expression ISO XRCC5 (Homo sapiens) 6480464 Endosulfan results in decreased expression of XRCC5 mRNA CTD PMID:26722802 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of XRCC5 mRNA CTD PMID:29391264 enzyme inhibitor multiple interactions ISO XRCC5 (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of XRCC5 protein CTD PMID:23301498 epoxiconazole multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of XRCC5 mRNA CTD PMID:29038839 ethanol multiple interactions EXP 6480464 [Fish Oils co-treated with Ethanol] results in increased expression of XRCC5 mRNA CTD PMID:17347304 etoposide affects response to substance ISO XRCC5 (Homo sapiens) 6480464 XRCC5 protein affects the susceptibility to Etoposide CTD PMID:12384553 fenofibrate multiple interactions EXP 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of XRCC5 mRNA CTD PMID:18253720 and PMID:18775883 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of XRCC5 mRNA CTD PMID:17264098 and PMID:18775883 finasteride increases expression EXP 6480464 Finasteride results in increased expression of XRCC5 mRNA CTD PMID:24136188 flutamide increases expression EXP 6480464 Flutamide results in increased expression of XRCC5 mRNA CTD PMID:24136188 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of XRCC5 mRNA CTD PMID:24793618 folic acid multiple interactions ISO Xrcc5 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of XRCC5 mRNA CTD PMID:22206623 formaldehyde decreases expression ISO XRCC5 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of XRCC5 mRNA CTD PMID:20655997 FR900359 increases phosphorylation ISO XRCC5 (Homo sapiens) 6480464 FR900359 results in increased phosphorylation of XRCC5 protein CTD PMID:37730182 fulvestrant decreases expression ISO XRCC5 (Homo sapiens) 6480464 fulvestrant results in decreased expression of XRCC5 mRNA CTD PMID:16514628 furan increases expression EXP 6480464 furan results in increased expression of XRCC5 mRNA CTD PMID:25539665 glucose multiple interactions ISO XRCC5 (Homo sapiens) 6480464 [2-hydroxyethyl disulfide co-treated with Glucose deficiency] results in decreased activity of [XRCC5 protein binds to XRCC6 protein] CTD PMID:22926048 gold atom decreases expression ISO XRCC5 (Homo sapiens) 6480464 Gold analog results in decreased expression of XRCC5 mRNA CTD PMID:36057382 gold(0) decreases expression ISO XRCC5 (Homo sapiens) 6480464 Gold analog results in decreased expression of XRCC5 mRNA CTD PMID:36057382 hydrogen peroxide multiple interactions ISO XRCC5 (Homo sapiens) 6480464 [Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of XRCC5 mRNA CTD PMID:21751221 hydroxyurea decreases expression ISO Xrcc5 (Mus musculus) 6480464 Hydroxyurea results in decreased expression of XRCC5 mRNA CTD PMID:12929121 hydroxyurea increases mutagenesis ISO Xrcc5 (Mus musculus) 6480464 Hydroxyurea results in increased mutagenesis of XRCC5 gene CTD PMID:16868089 irinotecan decreases expression ISO XRCC5 (Homo sapiens) 6480464 Irinotecan analog results in decreased expression of XRCC5 mRNA CTD PMID:18927307 ivermectin decreases expression ISO XRCC5 (Homo sapiens) 6480464 Ivermectin results in decreased expression of XRCC5 protein CTD PMID:32959892 lipopolysaccharide multiple interactions ISO XRCC5 (Homo sapiens) 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of XRCC5 mRNA CTD PMID:35877022 methimazole increases expression EXP 6480464 Methimazole results in increased expression of XRCC5 mRNA CTD PMID:30047161 methotrexate affects expression ISO Xrcc5 (Mus musculus) 6480464 Methotrexate affects the expression of XRCC5 mRNA CTD PMID:18502557 methyl methanesulfonate decreases expression ISO XRCC5 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of XRCC5 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO XRCC5 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of XRCC5 mRNA CTD PMID:28001369 N-methyl-N-nitrosourea increases mutagenesis ISO Xrcc5 (Mus musculus) 6480464 Methylnitrosourea results in increased mutagenesis of XRCC5 gene CTD PMID:16868089 N-nitrosodiethylamine multiple interactions ISO Xrcc5 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of XRCC5 mRNA CTD PMID:19690152 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of XRCC5 mRNA more ... CTD PMID:17602206 more ... nitrogen mustard affects response to substance ISO XRCC5 (Homo sapiens) 6480464 XRCC5 protein affects the susceptibility to Nitrogen Mustard Compounds CTD PMID:10717383 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of XRCC5 mRNA CTD PMID:37162024 ozone multiple interactions ISO Xrcc5 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of XRCC5 mRNA CTD PMID:34911549 ozone multiple interactions ISO XRCC5 (Homo sapiens) 6480464 [Air Pollutants results in increased abundance of Ozone] which affects the expression of XRCC5 mRNA CTD PMID:35430440 p-anisidine decreases expression ISO Xrcc5 (Mus musculus) 6480464 4-anisidine results in decreased expression of XRCC5 mRNA CTD PMID:12929121 paclitaxel decreases expression ISO Xrcc5 (Mus musculus) 6480464 Paclitaxel results in decreased expression of XRCC5 mRNA CTD PMID:12929121 paracetamol affects expression ISO Xrcc5 (Mus musculus) 6480464 Acetaminophen affects the expression of XRCC5 mRNA CTD PMID:17562736 paracetamol decreases expression ISO XRCC5 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of XRCC5 mRNA CTD PMID:21420995 and PMID:26497421 perfluorohexanesulfonic acid increases expression ISO Xrcc5 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in increased expression of XRCC5 mRNA CTD PMID:37995155 perfluorooctane-1-sulfonic acid increases expression ISO Xrcc5 (Mus musculus) 6480464 perfluorooctane sulfonic acid results in increased expression of XRCC5 protein CTD PMID:26178269 perfluorooctane-1-sulfonic acid multiple interactions ISO Xrcc5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of XRCC5 mRNA CTD PMID:36331819 phenethyl caffeate multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of XRCC5 mRNA CTD PMID:20360939 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of XRCC5 mRNA CTD PMID:30047161 picoxystrobin decreases expression ISO XRCC5 (Homo sapiens) 6480464 picoxystrobin results in decreased expression of XRCC5 mRNA CTD PMID:33512557 piperonyl butoxide affects expression ISO Xrcc5 (Mus musculus) 6480464 Piperonyl Butoxide affects the expression of XRCC5 mRNA CTD PMID:17014948 piperonyl butoxide multiple interactions ISO Xrcc5 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Piperonyl Butoxide] results in increased expression of XRCC5 mRNA CTD PMID:19690152 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of XRCC5 mRNA CTD PMID:19162173 and PMID:20127075 prochloraz multiple interactions EXP 6480464 [cyproconazole co-treated with epoxiconazole co-treated with prochloraz] results in increased expression of XRCC5 mRNA CTD PMID:29038839 quercetin decreases expression ISO XRCC5 (Homo sapiens) 6480464 Quercetin results in decreased expression of XRCC5 protein CTD PMID:19207037 raloxifene decreases expression ISO XRCC5 (Homo sapiens) 6480464 Raloxifene Hydrochloride results in decreased expression of XRCC5 mRNA CTD PMID:16514628 resveratrol multiple interactions ISO XRCC5 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of XRCC5 mRNA CTD PMID:23557933 rotenone decreases expression ISO XRCC5 (Homo sapiens) 6480464 Rotenone results in decreased expression of XRCC5 mRNA CTD PMID:33512557 sodium fluoride decreases expression ISO Xrcc5 (Mus musculus) 6480464 Sodium Fluoride results in decreased expression of XRCC5 protein CTD PMID:28918527 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of XRCC5 mRNA CTD PMID:30047161 sulindac decreases expression EXP 6480464 Sulindac results in decreased expression of XRCC5 mRNA CTD PMID:24136188 tetrachloromethane decreases expression ISO Xrcc5 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of XRCC5 mRNA CTD PMID:31919559 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of XRCC5 mRNA CTD PMID:34492290 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of XRCC5 mRNA CTD PMID:37258237 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of XRCC5 gene CTD PMID:27618143 trichostatin A increases acetylation ISO XRCC5 (Homo sapiens) 6480464 trichostatin A results in increased acetylation of XRCC5 protein CTD PMID:27064363 trichostatin A increases expression ISO XRCC5 (Homo sapiens) 6480464 trichostatin A results in increased expression of XRCC5 mRNA CTD PMID:24935251 trimellitic anhydride increases expression ISO Xrcc5 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of XRCC5 mRNA CTD PMID:19042947 valproic acid decreases expression ISO XRCC5 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of XRCC5 mRNA CTD PMID:23179753 and PMID:27188386 vorinostat decreases expression ISO XRCC5 (Homo sapiens) 6480464 vorinostat results in decreased expression of XRCC5 protein CTD PMID:16928817 and PMID:20646843 wortmannin multiple interactions ISO XRCC5 (Homo sapiens) 6480464 [wortmannin co-treated with docetaxel] results in decreased expression of XRCC5 protein CTD PMID:20878124